...
首页> 外文期刊>Andrologia >Differential research of inflammatory and related mediators in BPH BPH , histological prostatitis and PC PC a
【24h】

Differential research of inflammatory and related mediators in BPH BPH , histological prostatitis and PC PC a

机译:BPH BPH,组织学前列腺炎和PC PC中炎症和相关介质的差异研究

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Prostate cancer ( PC a) is one of the most common male malignancies in the world. It was aimed to investigate differential expression of inflammatory and related factors in benign prostatic hyperplasia ( BPH ), prostate cancer ( PC a), histological prostatitis ( HP ) and explore the role of Inducible nitric oxide synthase ( iNOS ), ( VEGF ) Vascular endothelial growth factor, androgen receptor ( AR ) and IL ‐2, IL ‐8 and TNF ‐α in the occurrence and development of prostate cancer. RT ‐ PCR was used to detect the mRNA expression level of iNOS , VEGF , AR and IL ‐2, IL ‐8 and TNF ‐α in BPH , PC a and BPH + HP . Western blotting and immunohistochemical staining were used to detect the protein levels of various proteins in three diseases. The results showed the mRNA and protein levels of iNOS , VEGF and IL ‐2, IL ‐8 and TNF ‐α were significantly increased in PC a and BPH + HP groups compared with BPH group ( p ??.05), while the AR was significantly lower than those in PC a and BPH + HP groups ( p ??.05). There was no significant difference in the mRNA and protein levels of iNOS , VEGF , AR and IL ‐2, IL ‐8 and TNF ‐α between PC a and BPH + HP groups ( p ??.05). iNOS , VEGF , AR and IL ‐2, IL ‐8 and TNF ‐α are involved in the malignant transformation of prostate tissue and play an important role in the development and progression of Prostate cancer (PCa).
机译:总结前列腺癌(PC A)是世界上最常见的男性恶性肿瘤之一。旨在探讨炎症和相关因素的患者良性前列腺增生(BPH),前列腺癌(PC A),组织学前列腺炎(HP)的差异表达,并探讨诱导型一氧化氮合酶(INOS),(VEGF)血管内皮的作用生长因子,雄激素受体(Ar)和IL-2,IL-8和TNF-α在前列腺癌的发生和发展中。 RT - PCR用于检测INOS,VEGF,Ar和IL-2,IL-8和TNF-α的mRNA表达水平,BPH,PC A和BPH + HP。蛋白质印迹和免疫组织化学染色用于检测三种疾病中各种蛋白质的蛋白质水平。结果表明,与BPH组(P =α.05)相比,PC A和BPH + HP组中,InOS,VEGF和IL -2,IL-8和TNF-α的mRNA和蛋白质水平显着增加(P?α.05)。 AR显着低于PC A和BPH + HP组(P≤0.05)中的ar。在PC A和BPH + HP组之间的MRNA,VEGF,Ar和IL-2,IL -8和TNF-α的mRNA和蛋白质水平没有显着差异(P?&Δ05)。 Inos,VEGF,Ar和IL-2,IL -8和TNF-α参与前列腺组织的恶性转化,并在前列腺癌(PCA)的开发和进展中发挥着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号